Eseroline

From Self-sufficiency
Jump to: navigation, search
Eseroline
200px
Systematic (IUPAC) name
(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol
Identifiers
CAS Number 469-22-7
ATC code none
PubChem CID 119198
Synonyms Eseroline
Chemical data
Formula C13H18N2O
Molar mass 218.295 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Eseroline is a drug which acts as an opioid agonist.[1] It is a metabolite of the acetylcholinesterase inhibitor physostigmine but unlike physostigmine, the acetylcholinesterase inhibition produced by eseroline is weak and easily reversible,[2][3] and it produces fairly potent analgesic effects mediated through the μ-opioid receptor.[4] This mixture of activities gives eseroline an unusual pharmacological profile,[5][6] although its uses are limited by side effects such as respiratory depression[7] and neurotoxicity.[8]



References

  1. ↑ Fürst S, Friedmann T, Bartolini A, Bartolini R, Aiello-Malmberg P, Galli A, Somogyi GT, Knoll J. Direct evidence that eseroline possesses morphine-like effects. European Journal of Pharmacology. 1982 Sep 24;83(3-4):233-41. PMID 6293841
  2. ↑ Jhamandas K, Elliott J, Sutak M. Opiatelike actions of eseroline, an eserine derivative. Canadian Journal of Physiology and Pharmacology. 1981 Mar;59(3):307-10. PMID 7194726
  3. ↑ Galli A, Renzi G, Grazzini E, Bartolini R, Aiello-Malmberg P, Bartolini A. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine. Biochemical Pharmacology. 1982 Apr 1;31(7):1233-8. PMID 7092918
  4. ↑ Agresti A, Buffoni F, Kaufman JJ, Petrongolo C. Structure-activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water. Molecular Pharmacology. 1980 Nov;18(3):461-7. PMID 7464812
  5. ↑ Galli A, Ranaudo E, Giannini L, Costagli C. Reversible inhibition of cholinesterases by opioids: possible pharmacological consequences. Journal of Pharmacy and Pharmacology. 1996 Nov;48(11):1164-8. PMID 8961166
  6. ↑ Liu WF. Effect of eseroline on schedule-controlled behavior in the rat. Pharmacology, Biochemistry and Behaviour. 1991 Apr;38(4):747-51. PMID 1871191
  7. ↑ Berkenbosch A, Rupreht J, DeGoede J, Olievier CN, Wolsink JG. Effects of eseroline on the ventilatory response to CO2. European Journal of Pharmacology. 1993 Feb 23;232(1):21-8. PMID 8458393
  8. ↑ Somani SM, Kutty RK, Krishna G. Eseroline, a metabolite of physostigmine, induces neuronal cell death. Toxicology and Applied Pharmacology. 1990 Oct;106(1):28-37. PMID 2251681


40px This analgesic-related article is a stub. You can help ssf by expanding it.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Eseroline&oldid=23428"